Literature DB >> 9783874

The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia.

A Rogers1, J C Day, B Williams, F Randall, P Wood, D Healy, R P Bentall.   

Abstract

The meaning of medication and the way in which people use medicines has been the focus of a number of studies in recent years. However, there has been little attention directed to the meaning and management of neuroleptic medication by people who have received a diagnosis of schizophrenia. This topic is highly relevant to policy because of the central role given to neuroleptics in contemporary mental health and community care services. Using data from in-depth interviews with people with a diagnosis of schizophrenia we explore patients reasons for taking neuroleptics and the ways in which patients self-regulate their medication. The data suggest that the main utility of taking neuroleptic medication is to control specific symptoms and to gain personal control over managing symptoms. The costs of taking medication were side-effects which at times equalised or outweighed the positive gains of the neuroleptic medication. Patient accounts suggest that everyday medication practices are to a significant degree related to a policy context which stresses the need to survey and control the behaviour of people living in the community and the wider meaning and symbolic significance that schizophrenia has for patients in their everyday lives. For this reason, self regulatory action in this group of patients tends to be less evident and the threat of external social control greater than patients taking medication for other chronic conditions. The findings suggest the need to develop a collaborative patient-centred model of medication management for patients diagnosed with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783874     DOI: 10.1016/s0277-9536(98)00209-3

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  20 in total

1.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

2.  Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.

Authors:  Christine M Wilder; Eric B Elbogen; Lorna L Moser; Jeffrey W Swanson; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2010-04       Impact factor: 3.084

3.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

Review 4.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

5.  Families and medication use and adherence among Latinos with schizophrenia.

Authors:  Mercedes Hernandez; Concepción Barrio
Journal:  J Ment Health       Date:  2016-10-01

6.  Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use.

Authors:  Anne Townsend; Kate Hunt; Sally Wyke
Journal:  BMJ       Date:  2003-10-11

7.  Empowerment and serious mental illness: treatment partnerships and community opportunities.

Authors:  Patrick W Corrigan
Journal:  Psychiatr Q       Date:  2002

8.  Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.

Authors:  Alexandra I Zugno; Ricardo Filipe Julião; Josiane Budni; Ana Maria Volpato; Daiane B Fraga; Felipe D Pacheco; Pedro F Deroza; Renata D Luca; Mariana B de Oliveira; Alexandra S Heylmann; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-06-19       Impact factor: 3.584

9.  Do patients' expectations influence their use of medications? Qualitative study.

Authors:  Lisa Dolovich; Kalpana Nair; Connie Sellors; Lynne Lohfeld; Annie Lee; Mitchell Levine
Journal:  Can Fam Physician       Date:  2008-03       Impact factor: 3.275

10.  Understanding the meaning of medications for patients: the medication experience.

Authors:  Sarah J Shoemaker; Djenane Ramalho de Oliveira
Journal:  Pharm World Sci       Date:  2007-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.